Cogent Biosciences files SEC disclosure on Hovione supply agreement
Cogent Biosciences disclosed an agreement with Hovione in an SEC filing, covering entry into a commercial supply agreement effective Sept. 1, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.